Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$487.30M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$491.55M
Gross Margin
42.92%
TTM Avg
41.39%
3Y Avg
40.24%
5Y Avg
40.24%
Market Cap
$478.54M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
20.00%
Market Cap
$471.57M
Gross Margin
52.05%
TTM Avg
54.84%
3Y Avg
54.67%
5Y Avg
54.23%
Market Cap
$517.73M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
-2215.86%
5Y Avg
-1460.58%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $487.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 42.92% | 41.39% | 40.24% | 40.24% |
| Evolus, Inc. (EOLS)vs › | $491.93M | 66.25% | 66.66% | 65.82% | 64.54% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 96.43% | 99.01% | 99.50% | 99.67% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.00% | 0.00% | 25.00% | 20.00% |
| Cerus Corporation (CERS)vs › | $471.57M | 52.05% | 54.84% | 54.67% | 54.23% |
| NRC Health (NRC)vs › | $468.31M | 56.33% | 58.27% | 60.30% | 61.48% |
| Kamada Ltd. (KMDA)vs › | $461.55M | 40.82% | 42.91% | 40.22% | 37.63% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | 0.00% | 50.00% | -2215.86% | -1460.58% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | 100.00% | 50.00% | 75.00% | 83.33% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
